{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:00:12Z","timestamp":1780966812516,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020149","name":"Consejo Estatal de Ciencia y Tecnolog\u00eda de Jalisco","doi-asserted-by":"crossref","award":["10209"],"award-info":[{"award-number":["10209"]}],"id":[{"id":"10.13039\/100020149","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04898-1","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:14:17Z","timestamp":1777101257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulatory effects of Pioglitazone on the CAF-driven malignant phenotype in cervical cancer: an in vitro bidirectional study"],"prefix":"10.1007","volume":"17","author":[{"given":"Carlos Daniel","family":"D\u00edaz-Palomera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Renee","family":"Gonz\u00e1lez-Lucano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Ren\u00e9","family":"Garc\u00eda-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Adri\u00e1n Ram\u00edrez","family":"de Arellano-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C\u00e9sar","family":"Villegas-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Villegas-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Jave-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Pereira-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"4898_CR1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3).","DOI":"10.3322\/caac.21660"},{"key":"4898_CR2","doi-asserted-by":"crossref","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. 40, J Obstet Gynaecol. 2020.","DOI":"10.1080\/01443615.2019.1634030"},{"key":"4898_CR3","doi-asserted-by":"crossref","unstructured":"Xiao L, Zhu H, Shu J, Gong D, Zheng D, Gao J. Overexpression of TGF-\u03b21 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration. Arch Gynecol Obstet. 2022;305(1).","DOI":"10.1007\/s00404-021-06137-0"},{"key":"4898_CR4","doi-asserted-by":"publisher","unstructured":"Xu M, Cao C, Wu P, Huang X, Ma D. Advances in cervical cancer: current insights and future directions. Cancer Commun [Internet]. 2025;45(2):77\u2013109. Available from: https:\/\/doi.org\/10.1002\/cac2.12629","DOI":"10.1002\/cac2.12629"},{"key":"4898_CR5","doi-asserted-by":"crossref","unstructured":"Diaz-Padilla I, Monk BJ, Mackay HJ, Oaknin A. Treatment of metastatic cervical cancer: Future directions involving targeted agents. 85, Critical Reviews in Oncology\/Hematology. 2013.","DOI":"10.1016\/j.critrevonc.2012.07.006"},{"key":"4898_CR6","doi-asserted-by":"crossref","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Volume 221. Pharmacology and Therapeutics; 2021.","DOI":"10.1016\/j.pharmthera.2020.107753"},{"key":"4898_CR7","doi-asserted-by":"crossref","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. 41, Cancer Cell. 2023.","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"4898_CR8","doi-asserted-by":"publisher","unstructured":"Truffi M, Sorrentino L, Corsi F. Fibroblasts in the Tumor Microenvironment. In: Birbrair A, editor. Tumor Microenvironment: Non-Hematopoietic Cells [Internet]. Cham: Springer International Publishing; 2020. pp. 15\u201329. Available from: https:\/\/doi.org\/10.1007\/978-3-030-37184-5_2","DOI":"10.1007\/978-3-030-37184-5_2"},{"key":"4898_CR9","doi-asserted-by":"crossref","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E. In search of definitions: Cancer-associated fibroblasts and their markers. 146, Int J Cancer. 2020.","DOI":"10.1002\/ijc.32193"},{"key":"4898_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14346","author":"N MiyaiY, Esaki","year":"2020","unstructured":"Miyai Y, Esaki N, Takahashi M, Enomoto A. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives. Cancer Sci. 2020. https:\/\/doi.org\/10.1111\/cas.14346","journal-title":"Cancer Sci"},{"key":"4898_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061899","author":"T WrightK, Ly","year":"2023","unstructured":"Wright K, Ly T, Kriet M, Czirok A, Thomas SM. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15061899","journal-title":"Cancers"},{"issue":"1","key":"4898_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41420-024-02053-9","volume":"10","author":"C LiX, Gonz\u00e1lez-Maroto","year":"2024","unstructured":"Li X, Gonz\u00e1lez-Maroto C, Tavassoli M. Crosstalk between CAFs and tumour cells in head and neck cancer. Cell Death Discov. 2024;10(1):303. https:\/\/doi.org\/10.1038\/s41420-024-02053-9","journal-title":"Cell Death Discov"},{"key":"4898_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155486","author":"M SperbN, Tsesmelis","year":"2020","unstructured":"Sperb N, Tsesmelis M, Wirth T. Crosstalk between tumor and stromal cells in pancreatic ductal adenocarcinoma. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21155486","journal-title":"Int J Mol Sci"},{"key":"4898_CR14","doi-asserted-by":"publisher","unstructured":"Miller BW, Willett KC, Desilets AR. Rosiglitazone and Pioglitazone for the Treatment of Alzheimer\u2019s Disease. Ann Pharmacother. 2011;45(11). https:\/\/doi.org\/10.1345\/aph.1q238","DOI":"10.1345\/aph.1q238"},{"key":"4898_CR15","doi-asserted-by":"publisher","unstructured":"Pan HW, Xu JT, Chen JS. Pioglitazone inhibits TGF\u03b2 induced keratocyte transformation to myofibroblast and extracellular matrix production. Mol Biol Rep. 2011;38(7). https:\/\/doi.org\/10.1007\/s11033-010-0581-5","DOI":"10.1007\/s11033-010-0581-5"},{"key":"4898_CR16","doi-asserted-by":"publisher","unstructured":"N\u00e9meth \u00c1, M\u00f3zes MM, Calvier L, Hansmann G, K\u00f6k\u00e9ny G. The PPAR\u03b3agonist pioglitazone prevents TGF-\u03b2 induced renal fibrosis by repressing EGR-1 and STAT3. BMC Nephrol. 2019;20(1). https:\/\/doi.org\/10.1186\/s12882-019-1431-x","DOI":"10.1186\/s12882-019-1431-x"},{"key":"4898_CR17","doi-asserted-by":"publisher","unstructured":"Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, et al. The Peroxisome Proliferator-Activated Receptor-\u03b3 Agonist Pioglitazone Represses Inflammation in a Peroxisome Proliferator-Activated Receptor-\u03b1-Dependent Manner In Vitro and In Vivo in Mice. J Am Coll Cardiol. 2008;52(10). https:\/\/doi.org\/10.1016\/j.jacc.2008.04.055","DOI":"10.1016\/j.jacc.2008.04.055"},{"key":"4898_CR18","doi-asserted-by":"publisher","unstructured":"ElGazzar WB, Allam MM, Shaltout SA, Mohammed LA, Sadek AM, Nasr HE. Pioglitazone modulates immune activation and ameliorates inflammation induced by injured renal tubular epithelial cells via PPAR\u03b3\/miRNA-124\/STAT3 signaling. Biomed Rep. 2023;18(1). https:\/\/doi.org\/10.3892\/br.2022.1584","DOI":"10.3892\/br.2022.1584"},{"issue":"2","key":"4898_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/J.YEXCR.2017.02.020","volume":"353","author":"L WuertzBR, Darrah","year":"2017","unstructured":"Wuertz BR, Darrah L, Wudel J, Ondrey FG. Thiazolidinediones abrogate cervical cancer growth. Exp Cell Res. 2017;353(2):63\u201371. https:\/\/doi.org\/10.1016\/J.YEXCR.2017.02.020","journal-title":"Exp Cell Res"},{"issue":"2","key":"4898_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yexcr.2017.02.020","volume":"353","author":"BR Wuertz","year":"2017","unstructured":"Plissonnier ML, Fauconnet S, Bittard H, Mougin C, Rommelaere J, Lascombe I. Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells. Oncotarget. 2017;8(64).","journal-title":"Exp Cell Res"},{"issue":"5","key":"4898_CR21","doi-asserted-by":"publisher","first-page":"102059","DOI":"10.1016\/j.jsps.2024.102059","volume":"32","author":"LA AlqahtaniQH, Alkharashi","year":"2024","unstructured":"Alqahtani QH, Alkharashi LA, Alajami H, Alkharashi I, Alkharashi L, Alhinti SN. Pioglitazone enhances cisplatin\u2019s impact on triple-negative breast cancer: Role of PPAR\u03b3 in cell apoptosis. Saudi Pharm J. 2024;32(5):102059. https:\/\/doi.org\/10.1016\/j.jsps.2024.102059","journal-title":"Saudi Pharm J"},{"key":"4898_CR22","doi-asserted-by":"publisher","unstructured":"Martinotti S, Ranzato E. Scratch wound healing assay. In: Methods in Molecular Biology. 2020. https:\/\/doi.org\/10.1007\/7651_2019_259","DOI":"10.1007\/7651_2019_259"},{"key":"4898_CR23","doi-asserted-by":"publisher","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6). https:\/\/doi.org\/10.1016\/j.ccr.2014.04.021","DOI":"10.1016\/j.ccr.2014.04.021"},{"key":"4898_CR24","doi-asserted-by":"crossref","unstructured":"\u00d6zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6).","DOI":"10.1016\/j.ccr.2014.04.005"},{"key":"4898_CR25","volume-title":"Choosing between glycolysis and oxidative phosphorylation: A tumor\u2019s dilemma? Volume 1807","author":"C Jose","year":"2011","unstructured":"Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: A tumor\u2019s dilemma? Volume 1807. Biochimica et Biophysica Acta - Bioenergetics; 2011."},{"key":"4898_CR26","doi-asserted-by":"crossref","unstructured":"Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? 41, Trends in Biochemical Sciences. 2016.","DOI":"10.1016\/j.tibs.2016.01.004"},{"key":"4898_CR27","doi-asserted-by":"crossref","unstructured":"Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44(5).","DOI":"10.1042\/BST20160094"},{"key":"4898_CR28","doi-asserted-by":"crossref","unstructured":"Demircioglu F, Wang J, Candido J, Costa ASH, Casado P, de Luxan Delgado B et al. Cancer associated fibroblast FAK regulates malignant cell metabolism. Nat Commun. 2020;11(1).","DOI":"10.1038\/s41467-020-15104-3"},{"key":"4898_CR29","doi-asserted-by":"crossref","unstructured":"Weinberg F, Ramnath N, Nagrath D. Reactive oxygen species in the tumor microenvironment: An overview. Vol. 11, Cancers. 2019.","DOI":"10.3390\/cancers11081191"},{"key":"4898_CR30","doi-asserted-by":"crossref","unstructured":"Idelchik M, del Begley PS, Begley U, Melendez TJ. JA. Mitochondrial ROS control of cancer. 47, Sem Cancer Biol. 2017.","DOI":"10.1016\/j.semcancer.2017.04.005"},{"key":"4898_CR31","doi-asserted-by":"crossref","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. 22, Nat Rev Cancer. 2022.","DOI":"10.1038\/s41568-021-00435-0"},{"key":"4898_CR32","doi-asserted-by":"crossref","unstructured":"Xia P, Pan Y, Zhang F, Wang N, Wang E, Guo Q et al. Pioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1\/RAGE and Rac1\/ROS Pathway by Activating PPAR. Cell Physiol Biochem. 2018;45(6).","DOI":"10.1159\/000488183"},{"key":"4898_CR33","doi-asserted-by":"crossref","unstructured":"Karunakaran U, Elumalai S, Moon JS, Won KC. Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic \u03b2-cell dysfunction by glutathione antioxidant system. Redox Biol. 2021;45.","DOI":"10.1016\/j.redox.2021.102029"},{"key":"4898_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhang X, Meng L, Gong M, Li J, Shi W et al. Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-\u03b3\/PGC-1\u03b1 Signaling Pathway. Front Pharmacol. 2021;12.","DOI":"10.3389\/fphar.2021.658362"},{"key":"4898_CR35","doi-asserted-by":"crossref","unstructured":"Ciaramella V, Sasso FC, Liello DI, Corte R, Della CM, Barra G, Viscardi G et al. Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC. J Experimental Clin Cancer Res. 2019;38(1).","DOI":"10.1186\/s13046-019-1176-1"},{"key":"4898_CR36","doi-asserted-by":"crossref","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8(23).","DOI":"10.4161\/cc.8.23.10238"},{"key":"4898_CR37","doi-asserted-by":"crossref","unstructured":"Arcucci A, Ruocco MR, Granato G, Sacco AM, Montagnani S. Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts. Vol. 2016, BioMed Research International. 2016.","DOI":"10.1155\/2016\/4502846"},{"key":"4898_CR38","doi-asserted-by":"crossref","unstructured":"Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M et al. The reverse Warburg effect is likely to be an Achilles\u2019 heel of cancer that can be exploited for cancer therapy. Vol. 8, Oncotarget. 2017.","DOI":"10.18632\/oncotarget.18175"},{"issue":"7","key":"4898_CR39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/cells13070560","volume":"13","author":"LJ Bueno-Urquiza","year":"2024","unstructured":"Bueno-Urquiza LJ, God\u00ednez-Rub\u00ed M, Villegas-Pineda JC, Vega-Maga\u00f1a AN, Jave-Su\u00e1rez LF, Puebla-Mora AG, et al. Phenotypic Heterogeneity of Cancer Associated Fibroblasts in Cervical Cancer Progression: FAP as a Central Activation Marker. Cells. 2024;13(7):560.","journal-title":"Cells"},{"key":"4898_CR40","doi-asserted-by":"crossref","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancerassociated fibroblasts. Physiol Rev. 2021;101(1).","DOI":"10.1152\/physrev.00048.2019"},{"key":"4898_CR41","doi-asserted-by":"crossref","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y et al. Il1-induced Jak\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9(2).","DOI":"10.1158\/2159-8290.CD-18-0710"},{"key":"4898_CR42","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu M, Yao Y, Li Y, Zhang S, Fu Y et al. Extracellular cancer-associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor-promoting roles and prognosis biomarker functions. Oncol Lett. 2024;27(4).","DOI":"10.3892\/ol.2024.14300"},{"key":"4898_CR43","doi-asserted-by":"crossref","unstructured":"Nakai N, Hara M, Takahashi H, Shiga K, Hirokawa T, Maeda Y et al. Cancer cell-induced tissue inhibitor of metalloproteinase-1 secretion by cancer-associated fibroblasts promotes cancer cell migration. Oncol Rep. 2022;47(6).","DOI":"10.3892\/or.2022.8323"},{"key":"4898_CR44","doi-asserted-by":"crossref","unstructured":"Hu C, Wang Z, Zhai L, Yang M, Shan L, Chai C et al. Effects of cancer-associated fibroblasts on the migration and invasion abilities of SGC-7901 gastric cancer cells. Oncol Lett. 2013;5(2).","DOI":"10.3892\/ol.2012.1023"},{"key":"4898_CR45","doi-asserted-by":"crossref","unstructured":"Dourado MR, Korvala J, \u00c5str\u00f6m P, De Oliveira CE, Cervigne NK, Mofatto LS et al. Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma. J Extracell Vesicles. 2019;8(1).","DOI":"10.1080\/20013078.2019.1578525"},{"key":"4898_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-010-0637-9","volume":"349","author":"Z Wan","year":"2011","unstructured":"Wan Z, Shi W, Shao B, Shi J, Shen A, Ma Y, et al. Peroxisome proliferator-activated receptor \u03b3 agonist pioglitazone inhibits \u03b2-catenin-mediated glioma cell growth and invasion. Mol Cell Biochem. 2011;349:1\u20132.","journal-title":"Mol Cell Biochem"},{"key":"4898_CR47","doi-asserted-by":"publisher","unstructured":"Xu YY, Liu H, Su L, Xu N, Xu DH, Liu HY, et al. PPAR\u03b3 inhibits breast cancer progression by upregulating PTPRF expression. Eur Rev Med Pharmacol Sci. 2019;23(22). https:\/\/doi.org\/10.26355\/eurrev_201911_19563","DOI":"10.26355\/eurrev_201911_19563"},{"key":"4898_CR48","doi-asserted-by":"publisher","unstructured":"Tian X, Yang C, Yang L, Sun Q, Liu N. PTPRF as a novel tumor suppressor through deactivation of ERK1\/2 signaling in gastric adenocarcinoma. Onco Targets Ther. 2018;11. https:\/\/doi.org\/10.2147\/OTT.S178152","DOI":"10.2147\/OTT.S178152"},{"key":"4898_CR49","doi-asserted-by":"publisher","unstructured":"Chi T, Wang M, Wang X, Yang K, Xie F, Liao Z, et al. PPAR-\u03b3 Modulators as Current and Potential Cancer Treatments. Frontiers in Oncology. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.737776","DOI":"10.3389\/fonc.2021.737776"},{"key":"4898_CR50","doi-asserted-by":"publisher","unstructured":"Srivastava N, Kollipara RK, Singh DK, Sudderth J, Hu Z, Nguyen H, et al. Inhibition of cancer cell proliferation by PPAR\u03b3 is mediated by a metabolic switch that increases reactive oxygen species levels. Cell Metab. 2014;20(4). https:\/\/doi.org\/10.1016\/j.cmet.2014.08.003","DOI":"10.1016\/j.cmet.2014.08.003"},{"key":"4898_CR51","doi-asserted-by":"publisher","unstructured":"Li H, Wang Q, Dong L, Liu C, Sun Z, Gao L, et al. Morusin suppresses breast cancer cell growth in vitro and in vivo through C\/EBP\u03b2 and PPAR\u03b3 mediated lipoapoptosis. J Experimental Clin Cancer Res. 2015;34(1). https:\/\/doi.org\/10.1186\/s13046-015-0252-4","DOI":"10.1186\/s13046-015-0252-4"},{"key":"4898_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1184794","author":"L SunJ, Yu","year":"2023","unstructured":"Sun J, Yu L, Qu X, Huang T. The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1184794","journal-title":"Front Pharmacol"},{"key":"4898_CR53","doi-asserted-by":"crossref","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. 15, Nat Reviews Clin Oncol. 2018.","DOI":"10.1038\/nrclinonc.2018.8"},{"key":"4898_CR54","doi-asserted-by":"crossref","unstructured":"Wang SW, Sun YM. The IL-6\/JAK\/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review). 44, Int J Oncol. 2014.","DOI":"10.3892\/ijo.2014.2259"},{"key":"4898_CR55","doi-asserted-by":"crossref","unstructured":"Xiao L, Li X, Cao P, Fei W, Zhou H, Tang N et al. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway. J Experimental Clin Cancer Res. 2022;41(1).","DOI":"10.1186\/s13046-022-02376-4"},{"key":"4898_CR56","doi-asserted-by":"crossref","unstructured":"Li X, Zhai J, Shen Y, Zhang T, Wang Y, He Y et al. Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8\u2009+\u2009T cells. Cancer Immunol Immunother. 2022;71(12).","DOI":"10.1007\/s00262-022-03223-3"},{"key":"4898_CR57","doi-asserted-by":"crossref","unstructured":"Kim S, Lee J, Jeon M, Lee JE, Nam SJ. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells. Tumor Biology. 2016;37(4).","DOI":"10.1007\/s13277-015-4345-7"},{"key":"4898_CR58","doi-asserted-by":"crossref","unstructured":"Geng X, Chen H, Zhao L, Hu J, Yang W, Li G et al. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. 9, Frontiers in Cell and Developmental Biology. 2021.","DOI":"10.3389\/fcell.2021.655152"},{"key":"4898_CR59","doi-asserted-by":"crossref","unstructured":"Hinz B. The role of myofibroblasts in wound healing. Curr Res Transl Med. 2016;64(4).","DOI":"10.1016\/j.retram.2016.09.003"},{"key":"4898_CR60","doi-asserted-by":"crossref","unstructured":"Baulida J. Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts. Vol. 11, Molecular Oncology. 2017.","DOI":"10.1002\/1878-0261.12080"},{"key":"4898_CR61","doi-asserted-by":"crossref","unstructured":"Fortier SM, Penke LR, King D, Pham TX, Ligresti G, Peters-Golden M. Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions. JCI Insight. 2021;6(6).","DOI":"10.1172\/jci.insight.144799"},{"key":"4898_CR62","doi-asserted-by":"crossref","unstructured":"Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T et al. PPAR-\u03b3 agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-\u03b2. Lab Invest. 2009;89(1).","DOI":"10.1038\/labinvest.2008.104"},{"key":"4898_CR63","doi-asserted-by":"crossref","unstructured":"Wang Z, Liu Q, Dai W, Hua B, Li H, Li W. Pioglitazone downregulates Twist-1 expression in the kidney and protects renal function of Zucker diabetic fatty rats. Biomed Pharmacotherapy. 2019;118.","DOI":"10.1016\/j.biopha.2019.109346"},{"key":"4898_CR64","doi-asserted-by":"crossref","unstructured":"Yuan GJ, Zhang ML, Gong ZJ. Effects of PPARg agonist pioglitazone on rat hepatic fibrosis. World J Gastroenterol. 2004;10(7).","DOI":"10.3748\/wjg.v10.i7.1047"},{"key":"4898_CR65","doi-asserted-by":"publisher","unstructured":"Theivendran S, Xian H, Qu J, Song Y, Sun B, Song H et al. A Pioglitazone Nanoformulation Designed for Cancer-Associated Fibroblast Reprogramming and Cancer Treatment. Nano Lett [Internet]. 2024;24(15):4354\u201361. Available from: https:\/\/doi.org\/10.1021\/acs.nanolett.3c04706","DOI":"10.1021\/acs.nanolett.3c04706"},{"key":"4898_CR66","doi-asserted-by":"crossref","unstructured":"Arango-Bravo EA, Cetina-P\u00e9rez L, del C, Galicia-Carmona T, Castro-Eguiluz D, Gallardo-Rinc\u00f3n D, Cruz-Bautista I et al. The health system and access to treatment in patients with cervical cancer in Mexico. 12, Front Oncol. 2022.","DOI":"10.3389\/fonc.2022.1028291"},{"key":"4898_CR67","doi-asserted-by":"crossref","unstructured":"Barquet-Mu\u00f1oz SA, Arteaga-G\u00f3mez C, D\u00edaz-L\u00f3pez E, Rodr\u00edguez-Trejo A, Marquez-Acosta J, Aranda-Flores C. Current status and challenges in timely detection of cervical cancer in Mexico: expert consensus. Frontiers in Oncology. Volume 14. Frontiers Media SA; 2024.","DOI":"10.3389\/fonc.2024.1383105"},{"key":"4898_CR68","doi-asserted-by":"publisher","unstructured":"Wei WY, Zhang N, Li LL, Ma ZG, Xu M, Yuan YP, et al. Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload. Cell Physiol Biochem. 2018;45(1). https:\/\/doi.org\/10.1159\/000486220","DOI":"10.1159\/000486220"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04898-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:32:13Z","timestamp":1780965133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04898-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4898"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04898-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Research Ethics Committee of the Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara (reference number: Cl-02325) and adhered to the Declaration of Helsinki, as well as to the General Health Law of Mexico on research in human samples. Written informed consent was obtained from all subjects before sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"869"}}